Beam stock forecast.

Beam Therapeutics last released its earnings results on November 8th, 2023. The reported ($1.22) earnings per share for the quarter, beating analysts' consensus estimates of ($1.33) by $0.11. The firm had revenue of $17.20 million for the quarter, compared to analyst estimates of $17.09 million. Its revenue was up 8.9% on a year-over-year basis.Nov 18, 2023 · Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per year. EPS is expected to decline by 3.5% per annum. Return on equity is forecast to be -82.9% in 3 years. Stock Forecast Based On a Predictive Algorithm | I Know First | Disclaimer: I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any …Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsStrong Buy Chart & Forecast Earnings Dividends Insider Trading Signals Historical Prices Predictions News Profile 3m (25.40%) 12m (-35.51%) Bollinger Bands …

7 brokers have issued 12-month price objectives for Sangamo Therapeutics' shares. Their SGMO share price targets range from $1.00 to $10.00. On average, they expect the company's stock price to reach $4.68 in the next twelve months. This suggests a possible upside of 1,150.3% from the stock's current price. View analysts price targets …Find real-time DDOG - Datadog Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter) $0.32: Annual revenue (last year) $1.7B: Annual profit (last ...

Find real-time DOCU - DocuSign Inc stock quotes, company profile, news and forecasts from CNN Business.

AR Stock 12 Months Forecast. Based on 13 Wall Street analysts offering 12 month price targets for Antero Resources in the last 3 months. The average price target is $33.33 with a high forecast of $38.00 and a low forecast of $25.00. The average price target represents a 15.07% change from the last price of $28.97.Based on 5 Buys and 4 Holds, the analyst consensus rates the stock a Moderate Buy. Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast) CareDx, Inc (CDNA) The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition.18/10/2023. IBA plans total system restoration on its first-ever proton therapy installation. Analytical report. Stock ION BEAM APPLICATIONS Common Stock BE0003766806 XBRU Euronext Brussels Live Euronext quotes, realtime prices, charts and regulated news.Find real-time MELI - MercadoLibre Inc stock quotes, company profile, news and forecasts from CNN Business.Inflation and geopolitical conflicts remain risks for investors. The stock market is entering the end of 2023 with major positive momentum, including an eight-day winning streak for the S&P 500 in ...

Find the latest Beam Therapeutics Inc. BEAM analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.

Stock Price Forecast The 12 analysts offering 12-month price forecasts for Beam Therapeutics Inc have a median target of 46.50, with a high estimate of 95.00 and a low estimate of 19.00.

Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per …BEST Inc. (NYSE:BEST) announced its earnings results on Monday, August, 16th. The company reported ($22.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($14.60) by $7.60. The business had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.26 billion.Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ...Nov 29, 2023 · The Fly Beam Therapeutics price target lowered to $26 from $35 at Barclays. 21d ago. Press Releases Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results. 22d ago. Press Releases Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference. 22d ago. According to 3 stock analysts, the average 12-month stock price forecast for Beam Global stock is $26.67, which predicts an increase of 343.02%. The lowest target is $25 and the highest is $30. On average, analysts rate Beam Global stock as a strong buy.Nov 29, 2023 · According to 3 stock analysts, the average 12-month stock price forecast for Beam Global stock is $26.67, which predicts an increase of 343.02%. The lowest target is $25 and the highest is $30. On average, analysts rate Beam Global stock as a strong buy.

Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Stock Price Forecast. The 23 analysts offering 12-month price forecasts for Nokia Oyj have a median target of 4.39, with a high estimate of 7.60 and a low estimate of 3.49. The median estimate ...7 brokers have issued 12-month price objectives for Sangamo Therapeutics' shares. Their SGMO share price targets range from $1.00 to $10.00. On average, they expect the company's stock price to reach $4.68 in the next twelve months. This suggests a possible upside of 1,150.3% from the stock's current price. View analysts price targets …Lead the world to clean mobility. We believe every person deserves access to safe, clean, reliable transportation. BEAM’s 100% sustainable EV charging solutions are the most rapidly deployed EV charging stations in the world. Fastest Deployed EV Charging In Action.Beam has raised a $9.5 million Series A round. The company is working on a new web browser that completely rethinks the way you start a web session and browse the web. The startup is founded by Dom Leca and Sébastien Métrot. Dom Leca previo...The Beam Therapeutics stock forecast for tomorrow is $ 27.79, which would represent a -6.02% loss compared to the current price. In the next week, the price of BEAM is expected to decrease by -2.93% and hit $ 28.70. As far as the long-term Beam Therapeutics stock forecast is concerned, here’s what our predictions are currently suggesting. Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...

Strong Buy Chart & Forecast Earnings Dividends Insider Trading Signals Historical Prices Predictions News Profile 3m (25.40%) 12m (-35.51%) Bollinger Bands …

Tritium shares are priced at $6.34 and their average price target of $14.40 implies an upside potential of ~127%. ( See Tritium stock forecast on TipRanks) Beam Global, the second EV charging ...John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ...Oct 28, 2023 · Beam Therapeutics Inc. (BEAM) share price prediction for 2023, 2024, 2025, 2026 and 2027. BEAM one year forecast. Beam Therapeutics stock monthly and weekly forecasts. Nov 29, 2023 · The Fly Beam Therapeutics price target lowered to $26 from $35 at Barclays. 21d ago. Press Releases Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results. 22d ago. Press Releases Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference. 22d ago. The average Beam Therapeutics stock forecast 2024 represents a 80.7% increase from the last price of $28.5900001525879. For Beam Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Beam Therapeutics stock forecast of $75.12, a high forecast of $83.03, and a low forecast of $61.46.Analyst Forecast. According to 2 analysts, the average rating for BEAT stock is "Strong Buy." The 12-month stock price forecast is $6.78, which is an increase of 361.22% from the latest price.Find real-time BEEM - Beam Global stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter)-$0.28: Annual revenue (last year) $22.0M: Annual profit (last ...Market outlook and 2024-2025 steel price forecasts. Taken together, MCI's judgement regarding the current level of steel prices in the context of the longer-term price cycle; with our assessment of expected changes to the steel supply demand balance in 2024; and our review of the near-term outlook for iron ore and coke prices – all point to a ...Dec 1, 2023 · According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $48.80 with a high price target of $105.00 and a low price target of $20.00. Learn more on ...

Find real-time NCLH - Norwegian Cruise Line Holdings Ltd stock quotes, company profile, news and forecasts from CNN Business.

7 brokers have issued 12-month price objectives for Sangamo Therapeutics' shares. Their SGMO share price targets range from $1.00 to $10.00. On average, they expect the company's stock price to reach $4.68 in the next twelve months. This suggests a possible upside of 1,150.3% from the stock's current price. View analysts price targets …

The stock of Beam Therapeutics (BEAM 5.31%), a clinical-stage genetic base-editing company, has shed 48% of its value relative to its 52-week high in recent weeks.BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I …Nov 25, 2023 · BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I take profit in Beam ... In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Beam Therapeutics (BEAM) Stock Forecast & Price Target $29.47 +1.52 (+5.44%) (As of 11/22/2023 ET) Compare Today's Range $28.24 $29.84 50-Day Range …According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00.The Biden administration is pushing hard to promote electric vehicles (EVs). From a $7.5 billion proIndustry. Packaged Software. No executives to display. Corporate headquarters. --, --. Find real-time AI - C3.ai Inc stock quotes, company profile, news and forecasts from CNN Business.

Find real-time AVGO - Broadcom Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter) $10.95: Annual revenue (last year) $33.2B: Annual profit ...11 brokers have issued 12 month price objectives for Beam Therapeutics' stock. Their BEAM share price targets range from $20.00 to $105.00. On average, they …BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I take profit in Beam ...Instagram:https://instagram. best motorhome loansvirtual private server tradingbest intro to coding coursevanguard value of an advisor According to analyst projections, BEAM’s forecast low is $19.00 with $95.00 as the target high. To hit the forecast high, the stock’s price needs a -219.33% plunge from its current level, while the stock would need to tank 36.13% for it to hit the projected low. Beam Therapeutics Inc (BEAM) estimates and forecastsApr 20, 2023 · Beam Therapeutics Inc Stock Price History. Beam Therapeutics Inc’s price is currently down 1.73% so far this month. During the month of April, Beam Therapeutics Inc’s stock price has reached a high of $32.82 and a low of $28.62. Over the last year, Beam Therapeutics Inc has hit prices as high as $73.27 and as low as $27.77. Year to date ... plug power inc newswhat company has the cheapest motorcycle insurance John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ...Oct 28, 2023 · Beam Therapeutics Inc. (BEAM) share price prediction for 2023, 2024, 2025, 2026 and 2027. BEAM one year forecast. Beam Therapeutics stock monthly and weekly forecasts. good oil stock to buy Stock Price Forecast. The 23 analysts offering 12-month price forecasts for Nokia Oyj have a median target of 4.39, with a high estimate of 7.60 and a low estimate of 3.49. The median estimate ...Well, it was only a matter of time. Advertising giant Facebook announced Wednesday that they’re going to begin testing advertising inside virtual reality titles on its Oculus platform soon. The first roll-out is limited enough, with Faceboo...